COVID-19 Therapeutics: Resources for Health Care Professionals and Public Health Officials

New and Notable: COVID-19 Therapeutics Announcements

March 2, 2023: COVID-19 and the PREP Act: Frequently Asked Questions
March 1, 2023: COVID-19 Medical Countermeasures Commercialization: Frequently Asked Questions
February 15, 2023: FDA Authorizes Additional Shelf-Life Extension for Sotrovimab
January 26, 2023: FDA Announces Evusheld is Not Currently Authorized for Emergency Use in the U.S.
January 18, 2023: Shelf-Life Extension for Specific Lots of Paxlovid
December 5, 2022: Shelf-Life Extension of Evusheld under Emergency Use Authorization

COVID-19 therapeutics can be used to prevent or treat eligible non-hospitalized patients who have tested positive for COVID-19 and have mild to moderate symptoms. Prevention and early treatment for eligible patients can help improve patient outcomes, reduce stress on healthcare facilities, and even save lives.

HHS/ASPR has purchased supplies of COVID-19 therapeutic products and we are working with state and territorial health departments as well as national healthcare and medical organizations and associations to get the treatments into the hands of healthcare providers quickly, with a focus on areas of the country hardest hit by the pandemic.